Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08FNJ
|
||||
Former ID |
DIB006001
|
||||
Drug Name |
RO-14
|
||||
Synonyms |
Very low molecular weight heparin (venous thromboembolism), Rovi
|
||||
Indication | Phlebothrombosis [ICD10:I80-I82] | Phase 1 | [522244] | ||
Company |
Laboratorios Farmaceuticos Rovi SA
|
||||
Target and Pathway | |||||
Target(s) | Antithrombin-III | Target Info | Modulator | [532712] | |
KEGG Pathway | Complement and coagulation cascades | ||||
PANTHER Pathway | Blood coagulation | ||||
Pathway Interaction Database | Glypican 1 network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.